SCHEMBL13117448

SCHEMBL13117448

COC(=O)c1cccc(-c2ccc(OCCOC(C)=O)c(OCCOC(C)=O)c2C)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.42
▸ HSP90AA1 P07900 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 5/20 0.40
▸ HSD17B10 Q99714 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ PDCD1 Q15116 1/20 0.37
▸ CD274 Q9NZQ7 1/20 0.37
▸ PTGER1 P34995 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13117445 0.88 KDM4E (0.46) MAPTHSP90AA1HTTNPSR1KDM4E
SCHEMBL13117473 0.84 MAPT (0.42) MAPTHSP90AA1HTTNPSR1KDM4E
SCHEMBL13117459 0.82 KDM4E (0.42) MAPTHSP90AA1HTTNPSR1KDM4E
SCHEMBL13117467 0.80 MAPT (0.39) MAPTHSP90AA1HTTNPSR1KDM4E
SCHEMBL13117618 0.80 ALDH1A1 (0.40) MAPTHTTKDM4EALDH1A1SMN1; SMN2
SCHEMBL2904151 0.76 ALDH1A1 (0.39) MAPTHSP90AA1HTTNPSR1KDM4E
SCHEMBL13117414 0.76 GAA (0.48) MAPTHSP90AA1HTTNPSR1KDM4E
SCHEMBL13117406 0.76 LMNA (0.49) MAPTHSP90AA1HTTNPSR1KDM4E
SCHEMBL19849652 0.75 TSHR (0.53) MAPTHTTNPSR1KDM4EALDH1A1
SCHEMBL29634134 0.75 TSHR (0.53) MAPTHTTNPSR1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267775-A1 OXADIAZOLIDINEDIONE COMPOUND ASTELLAS PHARMA INC. (JP) 2010-10-21 — — US disclosed
EP-2216330-A1 OXADIAZOLIDINEDIONE COMPOUND Astellas Pharma Inc. (JP) 2010-08-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267775-A1 OXADIAZOLIDINEDIONE COMPOUND GPR119, GLP1R, GPR4 MAPT 4712/4885HSP90AA1 2929/4885HTT 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback